Histamine function in brain disorders

The neurotransmitter histamine (HA) has been implicated in the regulation of numerous and important activities of the central nervous system as arousal, cognition, circadian rhythms and neuroendocrine regulation. The data presented here indicate the participation of the histaminergic system in central nervous system disorders, such as Alzheimer's disease and schizophrenia. We also present experimental data on histamine in an animal model of neurodegeneration and the cytotoxic effects of histamine on cultured rat endothelial cells. More studies are needed to investigate the role of the histaminergic system in central nervous system disorders. Peripheral cellular studies in health and disease, molecular studies on receptors and in vivo pharmacological studies may help us to better understand the function of the histaminergic system in health and disease.

[1]  J. Hjelle,et al.  Association of histamine with cerebral microvessels in regions of bovine brain , 1979, Brain Research.

[2]  B. Reisberg,et al.  The Global Deterioration Scale for assessment of primary degenerative dementia. , 1982, The American journal of psychiatry.

[3]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  N. Inagaki,et al.  Organization of the histaminergic system in the brain of the turtle Chinemys reevesii , 1990, The Journal of comparative neurology.

[5]  R. Wilson,et al.  Neuropsychology of Alzheimer's disease and other dementias , 1993 .

[6]  Maeyama Kazutaka,et al.  Tissue distribution of histamine in a mutant mouse deficient in mast cells: Clear evidence for the presence of non-mast-cell histamine , 1982 .

[7]  E. Stopa,et al.  Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease , 1995, Neurobiology of Aging.

[8]  H. Dale,et al.  The physiological action of β‐iminazolylethylamine , 1910 .

[9]  I. Mazurkiewicz-Kwilecki,et al.  Changes in the regional brain histamine and histidine levels in postmortem brains of Alzheimer patients. , 1989, Canadian journal of physiology and pharmacology.

[10]  D Ros,et al.  Prefrontal and temporal blood flow in schizophrenia: resting and activation technetium-99m-HMPAO SPECT patterns in young neuroleptic-naive patients with acute disease. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  H. Wolff,et al.  THE CEREBRAL CIRCULATION: X. The Action of Histamine , 1929 .

[12]  A. Green.  Neuroregulators and psychiatric disorders by E. Usdin, D. A. Hamburg and J. D. Barchas (eds.), 658 pages, Oxford University Press, London, 1977, £ 25.50 , 1978, Journal of the Neurological Sciences.

[13]  G Blomqvist,et al.  Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[14]  J. Denburg,et al.  Mast cell differentiation and heterogeneity. , 1985, Immunology today.

[15]  R. Cacabelos.  Diagnosis of Alzheimer's disease: defining genetic profiles (genotype vs phenotype) , 1996, Acta neurologica Scandinavica. Supplementum.

[16]  T. Erkinjuntti,et al.  CT in the differential diagnosis between Alzheimer's disease and vascular dementia , 1987, Acta neurologica Scandinavica.

[17]  P. Panula,et al.  Comparative neuroanatomy of the histaminergic system in the brain of the frog xenopus laevis , 1990, The Journal of comparative neurology.

[18]  B Jarrott,et al.  Isolated brain microvessels: preparation, morphology, histamine and catecholamine contents. , 1980, Blood vessels.

[19]  A. Yamatodani,et al.  Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders , 1994, Progress in Neurobiology.

[20]  J. Miguel-Hidalgo,et al.  Neuroprotective role of S12024 against neurodegeneration in the rat dentate gyrus , 1998, European Neuropsychopharmacology.

[21]  J. Palacios,et al.  The presence of two cellular pools of rat brain histamine , 1977, Journal of neurochemistry.

[22]  M. Tohyama,et al.  Organization of histaminergic fibers in the rat brain , 1988, The Journal of comparative neurology.

[23]  T. Theoharides,et al.  Mast cells: the immune gate to the brain. , 1990, Life sciences.

[24]  C. Cotman,et al.  Ultrastructural analysis of β-amyloid-induced apoptosis in cultured hippocampal neurons , 1994, Brain Research.

[25]  R. M. Pearson.  Frontiers in Histamine Research: a Tribute to Heinz Schild , 1986 .

[26]  H. Wada,et al.  High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: cation-exchange chromatography coupled with post-column derivatization fluorometry. , 1985, Journal of chromatography.

[27]  J. Miguel-Hidalgo,et al.  Effects of anapsos on the activity of the enzyme Cu-Zn-superoxide dismutase in an animal model of neuronal degeneration. , 1997, Methods and findings in experimental and clinical pharmacology.

[28]  J. Féger,et al.  Histaminergic pathway in rat brain evidenced by lesions of the medial forebrain bundle. , 1974, Science.

[29]  M. A. Bray,et al.  Interleukin 1 releases histamine from human basophils and mast cells in vitro. , 1987, Journal of immunology.

[30]  H. Braak,et al.  Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections , 1991, Brain pathology.

[31]  J. Green,et al.  Elevated levels of histamine metabolites in cerebrospinal fluid of aging, healthy humans. , 1988, Comprehensive gerontology. Section A, Clinical and laboratory sciences.

[32]  S. Grillner,et al.  Distribution of histaminergic neurons in the brain of the lamprey lampetra fluviatilis as revealed by histamine‐immunohistochemistry , 1990, The Journal of comparative neurology.

[33]  G. Schellenberg,et al.  The c-fos gene and early-onset familial Alzheimer's disease , 1993, Neuroscience Letters.

[34]  U. Pirvola,et al.  A histamine-containing neuronal system in human brain , 1990, Neuroscience.

[35]  G. Cosgrove,et al.  Cerebral amyloid angiopathy , 1985, Neurology.

[36]  N. Inagaki,et al.  Is the histaminergic neuron system a regulatory center for whole-brain activity? , 1991, Trends in Neurosciences.

[37]  J. Rommens,et al.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.

[38]  M. Adams,et al.  The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families , 1995, Nature Genetics.

[39]  J. Rinne,et al.  Neuronal histamine deficit in Alzheimer's disease , 1997, Neuroscience.

[40]  J. J. Dropp.  Mast cells in mammalian brain. , 1976, Acta anatomica.

[41]  S. D. Glick,et al.  Mast cells in rat thalamus: Nuclear localization, sex difference and left-right asymmetry , 1984, Brain Research.

[42]  C. Tanaka,et al.  Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia , 1991, Biological Psychiatry.

[43]  J. Schwartz,et al.  Pharmacological Characterization and Autoradiographic Localization of Histamine H2 Receptors in Human Brain Identified with [125I]Iodoaminopotentidine , 1992, Journal of neurochemistry.

[44]  S. Snyder,et al.  Neurotransmitter receptor binding in bovine cerebral microvessels. , 1980, Science.

[45]  R. Tanzi,et al.  REVIEWThe Gene Defects Responsible for Familial Alzheimer's Disease , 1996, Neurobiology of Disease.

[46]  F. Caird,et al.  Electroencephalography and computerised tomography in vascular and non-vascular dementia in old age. , 1978, Journal of neurology, neurosurgery, and psychiatry.

[47]  J. Schwartz,et al.  Histaminergic transmission in the mammalian brain. , 1991, Physiological reviews.

[48]  W. Kukull,et al.  Epidemiology of dementia: concepts and overview. , 2000, Neurologic clinics.

[49]  H. Ericson,et al.  Morphological analysis of the tuberomammmillary nucleus in the rat brain: Delineation of subgroups with antibody again L‐histidine decarboxylase as a marker , 1987, The Journal of comparative neurology.

[50]  C. Cotman,et al.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[51]  F. Joó,et al.  Carrier-mediated uptake and release of histamine by cultured rat cerebral endothelial cells , 1995, Neuroscience Letters.

[52]  P. Badia,et al.  Changes in circadian rhythms and sleep quality with aging: Mechanisms and interventions , 1995, Neuroscience & Biobehavioral Reviews.

[53]  J. Schwartz,et al.  Histamine as a transmitter in brain. , 1975, Life sciences.

[54]  J D Brodie,et al.  Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. , 1985, The American journal of psychiatry.

[55]  M. Mendez,et al.  Risk factors in Alzheimer's disease , 1992, Neurology.

[56]  V. Gallo,et al.  Expression of Excitatory Amino Acid Receptors by Cerebellar Cells of the Type‐2 Astrocyte Cell Lineage , 1989, Journal of neurochemistry.

[57]  T. Roth,et al.  Sedative effects of antihistamines. , 1987, The Journal of allergy and clinical immunology.

[58]  H. Thompson,et al.  Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. , 1986, The Journal of physiology.

[59]  R. Wyatt,et al.  Famotidine Adjunctive Pharmacotherapy for Schizophrenia: Preliminary Data , 1993, Clinical neuropharmacology.

[60]  H B Hechtman,et al.  Serotonin, norepinephrine, and histamine mediation of endothelial cell barrier function in vitro , 1986, Journal of cellular physiology.

[61]  E. Fuchs,et al.  Histaminergic system in the tree shrew brain , 1989, The Journal of comparative neurology.

[62]  K. McCarthy,et al.  Regulation of astroglial responsiveness to neuroligands in primary culture , 1993, Neuroscience.

[63]  A. Robinson-White,et al.  Presence of histamine and histamine-metabolizing enzyme in rat and guinea-pig microvascular endothelial cells. , 1982, The Journal of pharmacology and experimental therapeutics.

[64]  J. Miguel-Hidalgo,et al.  β-Amyloid(1–40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield , 1998, Acta Neuropathologica.

[65]  E. Ongini,et al.  Effects of nonsedating histamine H1-antagonists on EEG activity and behavior in the cat , 1989, Pharmacology Biochemistry and Behavior.

[66]  J. Kimura,et al.  Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer's disease , 1993, Neuroscience Letters.

[67]  N. Inagaki,et al.  Circadian rhythm of histamine release from the hypothalamus of freely moving rats , 1992, Physiology & Behavior.

[68]  S. Hill,et al.  Distribution, properties, and functional characteristics of three classes of histamine receptor. , 1990, Pharmacological reviews.

[69]  D. Pollen,et al.  The genetic defect causing familial Alzheimer's disease maps on chromosome 21. , 1987, Science.

[70]  S. Parvez.  Methods in biogenic amine research , 1983 .

[71]  C. Kaufmann,et al.  Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms , 1995, Schizophrenia Research.

[72]  J. Warner,et al.  Recombinant human IL-1 alpha and -1 beta potentiate IgE-mediated histamine release from human basophils. , 1989, Journal of immunology.

[73]  N. Inagaki,et al.  Characterization of histamine H1-receptors on astrocytes in primary culture: [3H]mepyramine binding studies. , 1989, European journal of pharmacology.

[74]  S. Galli,et al.  New concepts about the mast cell. , 1993, The New England journal of medicine.

[75]  N. Inagaki,et al.  Organization of the histaminergic system in the brain of the teleost, Trachurus trachurus , 1991, The Journal of comparative neurology.

[76]  J. Tanaka,et al.  Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decar☐ylase as a marker , 1984, Brain Research.

[77]  H. Takagi,et al.  Histaminergic axons in the neostriatum and cerebral cortex of the rat: a correlated light and electron microscopic immunocytochemical study using histidine decar☐ylase as a marker , 1986, Brain Research.

[78]  Y. Kubota,et al.  Fine structure of histaminergic neurons in the caudal magnocellular nucleus of the rat as demonstrated by immunocytochemistry using histidine decarboxylase as a marker , 1984, The Journal of comparative neurology.

[79]  J. Lucy.  Histamine tolerance in schizophrenia. , 1954, A.M.A. archives of neurology and psychiatry.

[80]  P. Panula,et al.  Histamine-containing neurons in the rat hypothalamus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[81]  A. Paetau,et al.  Histamine neurons in human hypothalamus: Anatomy in normal and alzheimer diseased brains , 1991, Neuroscience.

[82]  F. Joó,et al.  Lack of Histamine Synthesis and Down-Regulation of H1 and H2 Receptor mRNA Levels by Dexamethasone in Cerebral Endothelial Cells , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[83]  L. Tuomisto,et al.  Brain histamine H3 receptors in rats with portacaval anastomosis: in vitro and in vivo studies , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[84]  E. Perry,et al.  Clinical neurochemistry: developments in dementia research based on brain bank material , 1998, Journal of Neural Transmission.

[85]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[86]  R. Cacabelos,et al.  Behavioral changes associated with different apolipoprotein E genotypes in dementia. , 1997, Alzheimer disease and associated disorders.

[87]  Mathias Schreckenberger,et al.  Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics , 1997, The Lancet.

[88]  J. Phillis.  The Regulation of Cerebral Blood Flow , 1993 .

[89]  M. Baudry,et al.  Histamine synthesis in the developing rat brain: Evidence for a multiple compartmentation , 1975, Brain Research.

[90]  W. Lorenz,et al.  A Sensitive and Specific Method for the Determination of Histamine in Human Whole Blood and Plasma , 1972 .

[91]  E. Middleton,et al.  Allergy, principles and practice , 1978 .

[92]  J. Bodine,et al.  Effect of famotidine on deficit symptoms of schizophrenia , 1990, The Lancet.

[93]  E. G. Erdös,et al.  Release of Histamine from Mast Cells by Vasoactive Peptides 1 , 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[94]  J. Schwartz,et al.  Loss of striatal histamine H2 receptors in Huntington's: Chorea but not in Parkinson's disease: Comparison with animal models , 1993, Synapse.

[95]  L. Fernández-Novoa,et al.  Blood levels of histamine, IL-1β, and TNF-α in patients with mild to moderate alzheimer disease , 1996 .

[96]  A. Juhász,et al.  Uptake, metabolism, and release of [3H]‐histamine by glial cells in primary cultures of chicken cerebral hemispheres , 1990, Glia.

[97]  P. Panula,et al.  The histaminergic system in the guinea pig central nervous system: An immunocytochemical mapping study using an antiserum against histamine , 1988, The Journal of comparative neurology.

[98]  E. Peskind,et al.  Alzheimer's disease and related disorders. , 2001, The Medical clinics of North America.

[99]  S. Galli,et al.  Mast cells as a source of multifunctional cytokines. , 1990, Immunology today.

[100]  T. Watanabe,et al.  In vitro increase of histidine decarboxylase activity and release of histamine by peritoneal resident cells of mast cell-deficient W/Wv mice; possible involvement of macrophages. , 1988, Journal of biochemistry.

[101]  N. Inagaki,et al.  Regional distribution of histamine in the brain of non-mammalian vertebrates , 1992, Brain Research.

[102]  J. Palacios,et al.  Studies on a Capillary‐Rich Fraction Isolated from Brain: Histaminic Components and Characterization of the Histamine Receptors Linked to Adenylate Cyclase , 1980, Journal of neurochemistry.

[103]  A. Goate,et al.  Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease , 1996, The Lancet.

[104]  R. Wyatt,et al.  An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacy. , 1996, Clinical neuropharmacology.

[105]  A. Roses,et al.  Apolipoprotein E Genotyping as a Diagnostic Adjunct for Alzheimer's Disease , 1997, International Psychogeriatrics.

[106]  R. Cacabelos,et al.  Brain histamine in Alzheimer's disease. , 1989, Methods and findings in experimental and clinical pharmacology.

[107]  J. Miguel-Hidalgo,et al.  Intrahippocampal injections of the beta-amyloid 1-28 fragment induces behavioral deficits in rats. , 1997, Methods and findings in experimental and clinical pharmacology.

[108]  S. Spector,et al.  Disposition of histamine in mammalian blood vessels. , 1972, The Journal of pharmacology and experimental therapeutics.

[109]  R. Buchanan,et al.  Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study. , 1994, The American journal of psychiatry.

[110]  K. Kaji,et al.  Decay-accelerating factor on human umbilical vein endothelial cells. Its histamine-induced expression and spontaneous rapid shedding from the cell surface. , 1994, Journal of immunology.